baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

HSBC TUR.WAR.OP.END. ICY/ DE000HS6J4L5 /

14.11.2024 17:37:29	Изменение-0.1600	Бид17:50:01	Предложение17:50:01	Базовый актив	Цена исполнения	Дата истечения	Тип опциона
2.1500EUR	-6.93%	2.1300 Величина цены спроса: 25,000	2.1400 Величина цены предложения: 25,000	Incyte Corporation	56.8819 USD	31.12.2078	Call

GlobeNewswire 27.08 Alex Bastian joins Memo Therapeutics AG as VP Commercial Strategy

GlobeNewswire 16.08 China Medical System （00867） Released its 2024 Interim Results: Steady Increase in Revenue and Profi...

GlobeNewswire 06.08 MacroGenics Provides Update on Corporate Progress, Second Quarter 2024 Financial Results

GlobeNewswire 01.08 Merus Announces Financial Results for the Second Quarter 2024 and Provides Business Update

GlobeNewswire 30.07 MacroGenics Announces Achievement of $100 Million in Milestones Related to Retifanlimab Collaboratio...

Newsfile Corp 17.07 Analysts Hunt for Undervalued Biotech Stocks

TeleTrader 09.07 US closes mostly higher after Fed's chair testimony

GlobeNewswire 25.06 China Medical System Completes Dosing of the First Subject in Phase III Bridging Trial of Ruxolitini...

GlobeNewswire 29.05 Lynch Carpenter Investigates Claims in Cencora, Inc. Data Breach

GlobeNewswire 28.05 Keros Therapeutics Appoints Jean-Jacques Bienaimé to its Board of Directors

GlobeNewswire 09.05 MacroGenics Provides Update on Corporate Progress, First Quarter 2024 Financial Results and Interim ...

GlobeNewswire 08.05 Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update

GlobeNewswire 30.04 Akero Therapeutics Appoints Scott Gangloff as Chief Technology Officer

GlobeNewswire 02.04 HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sin...

GlobeNewswire 01.04 CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast ...

GlobeNewswire 28.02 Merus Announces Financial Results for the Fourth Quarter and Full Year 2023 and Provides Business Up...

GlobeNewswire 09.01 Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030

TeleTrader 12.12.2023 Wall Street closes higher after inflation report

GlobeNewswire 09.12.2023 CURE Media Group announces winners of the 2023 MPN Heroes® Recognition Program

GlobeNewswire 16.11.2023 CURE Media Group® announces Jane Fonda as keynote speaker for the 2023 MPN Heroes® recognition progr...

GlobeNewswire 02.11.2023 Merus Announces Financial Results for the Third Quarter 2023 and Provides Business Update

GlobeNewswire 23.10.2023 Elevar Therapeutics Names Brian Cunningham Vice President of Sales and Kenneth Rankin Vice President...

GlobeNewswire 12.10.2023 Global CAR T-cell Therapy Market Projected to Reach $83 Billion by 2032

GlobeNewswire 27.09.2023 Arcutis Appoints L. Todd Edwards as Chief Commercial Officer

HSBC TUR.WAR.OP.END. ICY/ DE000HS6J4L5 /

Если вы хотите получить ответ на свой отзыв, укажите, пожалуйста, адрес своей электронной почты.